Picture of SenzaGen AB logo

SENZA SenzaGen AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: SenzaGen H2 Operating Loss Widens To SEK 17.5 Mln

Feb 11 (Reuters) - SenzaGen AB  SENZA.ST :
    * SENZAGEN’S YEAR-END REPORT 2021: STRONG PERFORMANCE WITH
MORE
THAN 150% GROWTH IN H2 AND NEARLY DOUBLED SALES FOR FULL YEAR
    * H2 OPERATING LOSS SEK 17.5 MILLION VERSUS SEK LOSS 14.2
MILLION
YEAR AGO
    * H2 NET SALES SEK 10.4 MILLION VERSUS SEK 4.1 MILLION YEAR
AGO
    * BOARD PROPOSES THAT NO DIVIDEND BE PAID TO COMPANY'S
SHAREHOLDERS
    * SALES GROWTH WILL REMAIN OUR HIGHEST PRIORITY IN 2022
WHILE WE
CONTINUE WORKING ON OUR ACQUISITION AGENDA, INTEGRATION OF
VITROSCREEN AND COMPLETING OECD TEST GUIDELINE PROCESS FOR
GARD®SKIN

Source text for Eikon:  ID:nMFN32lR4X 
Further company coverage:  SENZA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))

Recent news on SenzaGen AB

See all news